إعلان
إعلان
BNGO
Bionano Genomics, Inc. Common Stock
1.57
USDبرعاية
-0.03
-1.56%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
1.60
+0.03
+1.59%
تقارير أرباح BNGO
النسبة الإيجابية المفاجئة
BNGO تفوق 10 من 29 آخر التقديرات.
34%
التقرير التالي
بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$7.94M
/-$1.43
التغير الضمني من Q3 25 (Revenue/ EPS)
+7.81%
/-10.06%
التغير الضمني من Q4 24 (Revenue/ EPS)
-2.71%
/-90.97%
Bionano Genomics, Inc. Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, BNGO reported earnings of -1.59 USD per share (EPS) for Q3 25, beating the estimate of -1.94 USD, resulting in a 18.39% surprise. Revenue reached 7.37 مليون, compared to an expected 7.01 مليون, with a 5.12% difference. The market reacted with a +3.40% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of -1.43 USD, with revenue projected to reach 7.94 مليون USD, implying an نقصان of -10.06% EPS, and زيادة of 7.81% in Revenue from the last quarter.
الأسئلة الشائعة
What were Bionano Genomics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Bionano Genomics, Inc. Common Stock reported EPS of -$1.59, beating estimates by 18.39%, and revenue of $7.37M, 5.12% above expectations.
How did the market react to Bionano Genomics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 3.4%, changed from $1.47 before the earnings release to $1.52 the day after.
When is Bionano Genomics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
What are the forecasts for Bionano Genomics, Inc. Common Stock's next earnings report?
Based on 5
المحللين, Bionano Genomics, Inc. Common Stock is expected to report EPS of -$1.43 and revenue of $7.94M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان